# RTA 744 Injection in Patients With Leptomeningeal Disease

> **NCT00512460** · PHASE1 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 7 (actual)

## Conditions studied

- Neoplastic Meningitis
- Solid Tumor
- Lymphoma
- Leukemia
- Brain Tumor

## Interventions

- **DRUG:** RTA 744

## Key facts

- **NCT ID:** NCT00512460
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-09
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Study was closed due to loss of industry sponsorship
- **Last updated:** 2016-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00512460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00512460, "RTA 744 Injection in Patients With Leptomeningeal Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00512460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*